Back TC - Search Results

1

Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.

Wigginton JM, Kuhns DB, Back TC, Brunda MJ, Wiltrout RH, Cox GW. Wigginton JM, et al. Among authors: back tc. Cancer Res. 1996 Mar 1;56(5):1131-6. Cancer Res. 1996. PMID: 8640772

2

Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver.

Subleski JJ, Hall VL, Back TC, Ortaldo JR, Wiltrout RH. Subleski JJ, et al. Among authors: back tc. Cancer Res. 2006 Nov 15;66(22):11005-12. doi: 10.1158/0008-5472.CAN-06-0811. Cancer Res. 2006. PMID: 17108139

3

Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.

Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH. Wigginton JM, et al. Among authors: back tc. J Natl Cancer Inst. 1996 Jan 3;88(1):38-43. doi: 10.1093/jnci/88.1.38. J Natl Cancer Inst. 1996. PMID: 8847724

4

Evaluation of the antitumor activity of the interleukin-12/pulse interleukin-2 combination.

Wigginton JM, Komschlies KL, Green JE, Cox GW, Jorcyk CL, Back TC, Franco JL, Brunda MJ, Wiltrout RH. Wigginton JM, et al. Among authors: back tc. Ann N Y Acad Sci. 1996 Oct 31;795:434-9. doi: 10.1111/j.1749-6632.1996.tb52714.x. Ann N Y Acad Sci. 1996. PMID: 8958976 No abstract available.

5

Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype.

Gruys ME, Back TC, Subleski J, Wiltrout TA, Lee JK, Schmidt L, Watanabe M, Stanyon R, Ward JM, Wigginton JM, Wiltrout RH. Gruys ME, et al. Among authors: back tc. Cancer Res. 2001 Aug 15;61(16):6255-63. Cancer Res. 2001. PMID: 11507080

6

Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.

Damia G, Komschlies KL, Futami H, Back T, Gruys ME, Longo DL, Keller JR, Ruscetti FW, Wiltrout RH. Damia G, et al. Cancer Res. 1992 Aug 1;52(15):4082-9. Cancer Res. 1992. PMID: 1638519

7

Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma.

Khan T, Hixon JA, Stauffer JK, Lincoln E, Back TC, Brenner J, Lockett S, Nagashima K, Powell D, Wigginton JM. Khan T, et al. Among authors: back tc. J Natl Cancer Inst. 2006 Feb 1;98(3):190-202. doi: 10.1093/jnci/djj021. J Natl Cancer Inst. 2006. PMID: 16449679

8

Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Stauffer JK, Scarzello AJ, Andersen JB, De Kluyver RL, Back TC, Weiss JM, Thorgeirsson SS, Wiltrout RH. Stauffer JK, et al. Among authors: back tc. Cancer Res. 2011 Apr 1;71(7):2718-27. doi: 10.1158/0008-5472.CAN-10-2705. Epub 2011 Feb 15. Cancer Res. 2011. PMID: 21324921 Free PMC article.

9

In vivo distribution and cytokine gene expression by enriched mouse LAK effector cells.

Futami H, Pilaro AM, Gruys ME, Back TC, Young HA, Wiltrout RH. Futami H, et al. Among authors: back tc. Biotherapy. 1991;3(3):219-32. doi: 10.1007/BF02171685. Biotherapy. 1991. PMID: 1906724

10

Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.

Hornung RL, Back TC, Zaharko DS, Urba WJ, Longo DL, Wiltrout RH. Hornung RL, et al. Among authors: back tc. J Immunol. 1988 Nov 15;141(10):3671-9. J Immunol. 1988. PMID: 2460546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters